With millions of Americans now using semaglutide, tirzepatide, and related therapies, RDNs are encountering new patterns of appetite suppression, food aversions, reduced portion tolerance, digestive sensitivities, and changing attitudes toward alcohol, indulgence, and social eating
Your healthcare team can help you distinguish between the two and adjust your doses accordingly
Welcome to a whole new level of rejuvenation
It helps eliminate toxins, neutralize free radicals, and reduce oxidative stress to support overall health
Another limitation of GLP-1 RAs is that discontinuation commonly leads to substantial body weight regain, and many patients who regain weight subsequently restart GLP-1 RA therapy, resulting in a recurrent cycle of body weight loss and gain [10]
So, its not surprising that they carry this risk of suicidal ideation but it doesnt mean that the drugs are unsafe. The FDA lists multiple GLP-1 drugs under review for safety on Suicidal thoughts are not currently listed as a potential side effect of Ozempic and Wegovy, according to the FDAs drug label and the EU product information